Quick navigation menu :

  1. Go to the content
  2. Go to main section's menu
  3. Go to Search tool
  4. Go to Help menu
  5. Go to modules
  6. Go to the list of keyboard shortcuts

Help menu :

  1. Sanofi Worldwide |
     
  2. Our Websites |
     
  3. Global Business Websites |
     
  4. Contact |
  5. Sitemap |
  6. Help
  1. Font size

    Reduce Increase  
 
 

Metabolic Disorders

Contact

sanofi-aventis Philippines, Inc.

21F One World Place,
32nd St, Bonifacio Global City
1634 TAGUIG CITY , Philippines

Tel: (632) 859-5555
Fax: (632) 813-1676

Content :

Metabolic Disorders

Millions of people around the world suffer from diabetes and its complications. Diabetes currently affects nearly 200 million people worldwide and WHO statistics forecast that more than 300 million will be affected by the year 2025.

In the Philippines, almost three million people have diabetes (1) The number is projected to increase to more than six million by 2030.(2)

 

Diabetes

Brain damage, Eye complications, Heart attck, Impaired pancreatic function, Kidney failure, Risk of amputation, Possible complications

Diabetes is a chronic disease in which the body fails to produce or properly utilize insulin, a hormone that enables cells to absorb glucose and convert it into energy.  In people with diabetes, the system functions inadequately or not at all, leading to a high level of glucose in the blood known as hyperglycemia.

Cardiometabolic risk

Cardiometabolic risk is a term that refers to the overall risk of developing type 2 diabetes or cardiovascular disease.  It is linked to the presence of traditional risk factors such as hypercholesterolemia (a high rate of LDL or “bad” cholesterol in the blood), hypertension, type 2 diabetes and smoking, as well as to a cluster of emerging insulin resistance markers that are often present in patients with abdominal obesity (an excess of high-risk abdominal fat).  Research has shown that adipose tissue does not simply store fat; it also functions as an organ in its own right, releasing substances that can contribute to the development of cardiometabolic risk factors such as high levels of triglycerides and hyperglycemia, thus compounding the risk of diabetes and cardiovascular disease. In the United States, around 46% or men and women over the age of 20 suffer from abdominal obesity.

Updated February 01, 2017